Hikal Q1 FY27 Results: Revenue Rs 402 Cr, PAT Rs 7.00 Cr and Key Highlights
- August 7, 2026
- Posted by: Kunal Singla
- Category: News
Hikal Q1 FY27 results declared Aug 6, 2026. Revenue Rs 402 Cr (+5.89% YoY). Net Loss Rs 7.00 Cr (+66.96% YoY). CMP Rs 221.43 (-4.79%).
Hikal Q1 FY27 results were announced on August 6, 2026, on a Consolidated basis. Hikal Q1 FY27 results show revenue grew +5.89% year-on-year to Rs 402 Cr from Rs 380 Cr in Q1 FY26, reflecting sustained demand in the Chemicals segment.
Operating profit improved +60.14% YoY to Rs -5 Cr from Rs -14 Cr, indicating stronger operational efficiency. The company reported a net loss of Rs 7.00 Cr in Q1 FY27, narrowing from a loss of Rs 22.00 Cr in Q1 FY26, indicating a gradual recovery trajectory. The quarterly numbers offer a detailed picture of how the company is navigating the current chemicals environment.
Click Here – Get Free Investment Predictions
Hikal Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Hikal Revenue | 402 | 380 | +5.89% |
| Operating Profit | -5 | -14 | +60.14% |
| Net Profit (PAT) | -7.00 | -22 | +66.96% |
| Reporting Basis | Consolidated | ||
Hikal Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Hikal Q1 FY27 results reflect strong fundamentals across key financial parameters. Revenue momentum continued on a strong footing with the top line reaching Rs 402 Cr for the April to June 2026 quarter.
Operating profit stood at Rs -5 Cr, expanding +60.14% YoY. Margin improvement signals better cost absorption and product mix optimisation.
The net loss of Rs 7.00 Cr in Hikal Q1 FY27 results indicates that the turnaround is still in progress. Investors monitoring Hikal Q1 FY27 results will note this as a key milestone for FY27 tracking.
Key Business Factors in Hikal Q1 FY27 Results
Revenue Growth Momentum in the Chemicals Segment
Hikal Q1 FY27 results demonstrate consistent top-line expansion, with revenue rising +5.89% YoY to Rs 402 Cr. Volume-led growth and pricing discipline in key markets drove the uptick.
Operating Margin Expansion Signals Efficiency Gains
Operating profit in Hikal Q1 FY27 results rose +60.14% YoY to Rs -5 Cr. This reflects tighter cost control, better product mix, and operating leverage as the company scales volumes in core business lines.
Net Loss and Path Toward Profitability
Hikal Q1 FY27 results reflect a net loss of Rs 7.00 Cr. Management has outlined a roadmap to profitability through operational restructuring, debt reduction, and revenue scaling in higher-margin product lines.
Dividend Details
No dividend was announced along with Hikal Q1 FY27 results. The company is likely retaining earnings for reinvestment into growth capex and working capital requirements.
FY27 Outlook for Hikal
Hikal is positioned to maintain growth momentum into Q2 FY27 and beyond, supported by order visibility, operational improvements, and sector tailwinds. Management guidance points toward continued expansion in the Chemicals business with a focus on margin improvement and market share consolidation. Investors tracking Hikal Q1 FY27 results are advised to consult a SEBI-registered financial advisor before making decisions.
Hikal Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Hikal live price and get daily stock recommendations.
Hikal shares were trading lower at Rs 221.43 (-4.79%) on August 6, 2026, following the declaration of Hikal Q1 FY27 results. The stock reaction reflects investor sentiment on near-term earnings trajectory and sector outlook. CMP stood at Rs 221.43 on the results date, with a 52-week range reflecting the broader market sentiment toward the chemicals sector.
Key Risks for Hikal
Sector-Specific Headwinds
Feedstock price volatility and Chinese competition in commodity chemicals remain risks.
Valuation and Earnings Risk
Valuation risk remains if earnings growth fails to sustain at current levels over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level losses or underperformance in overseas operations could drag consolidated PAT lower.
Conclusion
Hikal Q1 FY27 results reflect near-term operational challenges with revenue at Rs 402 Cr and a net loss of Rs 7.00 Cr on a Consolidated basis. The management’s ability to execute its recovery plan will determine the stock’s re-rating potential. Investors are advised to monitor quarterly progress before making investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Hikal Q1 FY27 Results
When were Hikal Q1 FY27 results declared?
Ans. Hikal Q1 FY27 results were declared on August 6, 2026. The results cover the April to June 2026 quarter on a Consolidated basis.
What was Hikal revenue in Q1 FY27?
Ans. Hikal Q1 FY27 results show revenue of Rs 402 Cr, +5.89% compared to Rs 380 Cr in Q1 FY26.
What was Hikal PAT in Q1 FY27?
Ans. Net loss in Hikal Q1 FY27 results was Rs 7.00 Cr, +66.96% year-on-year.
Did Hikal declare a dividend in Q1 FY27?
Ans. No dividend was declared alongside Hikal Q1 FY27 results. Investors should check the official company announcements on BSE and NSE for any future dividend declarations.
What is the FY27 outlook for Hikal?
Ans. Hikal management has outlined a focus on revenue scaling and margin improvement for the remainder of FY27. Sector tailwinds and order book visibility will be key monitorables.
How did the Hikal stock react to Q1 FY27 results?
Ans. Hikal shares were trading lower at Rs 221.43 (-4.79%) on August 6, 2026, following the Hikal Q1 FY27 results announcement. Investors should consult a SEBI-registered financial advisor before acting on price movements.
